Interpol is on the hunt for fugitives accused of such crimes as ivory smuggling. illegal logging, and trafficking live animals
The cosmetics retailer is facing a lawsuit
The oil market has moved beyond the Keystone XL pipeline
A new tool detects computer malware that’s watching your every move
The provider of high-interest business loans nears an IPO, on the strength of its data-powered credit analysis—and a network of shady brokers
Nike expects revenue from women to outpace its men's business.
Twist, stretch, twirl: a day in the life of a candy cane
Educational Credit Management, a guarantor and collector of student loans, wants to buy 56 campuses from Corinthian Colleges
The novelty items are hot for retailers large and small
Chairman and Managing Director, Sun Pharmaceuticals
Dilip Shanghvi's low-key management style has turned Sun Pharma, maker of generic and branded drugs, into one of the most profitable pharma companies in India. Sun's priorities include cardiology, neurology, and psychiatry drugs. Shanghvi pursued M&As at home and overseas at a time when Indian companies rarely went shopping. Having waged a two-year legal battle, he hopes to score a big win soon with Sun gaining control over generics drugmaker Taro Pharmaceuticals of Israel.